Monthly Archives: January 2012
Merck Millipore and Proteomics International sign biomarkers collaboration
Merck Millipore and Proteomics International have announced a collaboration to validate biomarkers related to diabetic nephropathy. Diabetic nephropathy is a significant complication of diabetes. Under the collaboration, Proteomics International will assess its thirteen newly identified putative protein biomarkers by using … Continue reading
Filed under alliances
KineMed signs non-exclusive research collaboration with Pfizer
KineMed has announced a non-exclusive research collaboration with Pfizer for the advancement of novel approaches towards metabolic disease, in particular Type II Diabetes. The collaboration will employ KineMed’s Dynamic Proteomics technology platform to map the impact of potential drug candidates … Continue reading
Filed under alliances
Valeant Pharmaceuticals withdraws offer to acquire ISTA Pharmaceuticals
Valeant Pharmaceuticals has announced that it has withdrawn its offer to acquire ISTA Pharmaceuticals. The bid was made in mid-December 2011 and valued ISTA Pharmaceuticals at $327 million.
Filed under acquisitions
The Drugs for Neglected Diseases Initiative and Abbott expand collaboration
The Drugs for Neglected Diseases Initiative and Abbott have announced that they have signed a four-year joint research and non-exclusive licensing agreement to undertake research on new treatments for several tropical diseases, including Chagas disease, helminth infections, leishmaniasis and sleeping … Continue reading
Filed under alliances
Actavis and Bioton form insulin joint-venture
Actavis and Bioton have announced that they have formed a joint venture company for the development and registration of insulins, including analogue insulins. In the joint-venture, Bioton will be responsible for the development and manufacture of insulin products, while Actavis … Continue reading
Filed under joint ventures
Roche executes alliance with Technoclon to co-develop coagulation assays
Roche has announced that it has entered into a strategic alliance with Technoclon to co-develop a range of coagulation assays. According to the companies, the alliance supports plans Roche announced in October 2011 to develop a new line of analyzers … Continue reading
Filed under alliances
Les Laboratoires Servier and Monash University sign GPRC collaboration agreement
Les Laboratoires Servier and Monash University have announced a collaborative agreement for drug discovery and research on G Protein Coupled Receptors. The collaboration will make use of MIPS’ capability in the identification of novel GPCR targets. The collaboration will initially … Continue reading
Filed under alliances
Novartis extends collaboration with GenVec
GenVec has announced that it has extended its collaboration agreement with Novartis. Under the extension, Novartis will fund research at GenVec through January 2013 to support its hearing loss and balance disorders program. In January 2010, GenVec entered into a … Continue reading
Filed under alliances
Amgen buys Micromet for $1.16 billion
Amgen and Micromet have announced that the companies have entered into a definitive merger agreement under which Amgen will acquire Micromet for approximately $1.16 billion. The acquisition includes blinatumomab, a Bispecific T cell Engager antibody in Phase 2 clinical development … Continue reading
Filed under acquisitions
Celgene buys Avila Therapeutics for $925 million
Celgene and Avila Therapeutics have announced an agreement under which Celgene will acquire Avila. According to the companies the acquisition positions Celgene to expand its role in the future treatment of hematologic cancers with Avila’s AVL-292, a selective Bruton’s tyrosine … Continue reading
Filed under acquisitions
